Article
Endocrinology & Metabolism
John J. Carey, Lan Yang, E. Erjiang, Tingyan Wang, Kelly Gorham, Rebecca Egan, Attracta Brennan, Mary Dempsey, Catherine Armstrong, Fiona Heaney, Eva McCabe, Ming Yu
Summary: Osteoporosis is a global health issue, with vertebral fractures being common in older men and women with low bone mineral density, previous fractures, and at high risk of future fractures. Urgent attention is needed to identify those at risk and reduce the burden of vertebral fractures. Ireland has high hip fracture rates but limited data on vertebral fractures, indicating the need for further research in this area.
CALCIFIED TISSUE INTERNATIONAL
(2021)
Article
Endocrinology & Metabolism
Michael Morkos, Paul Mahrous, Alessandra Casagrande, Muriel Tania Go, Hasan Husni, Mirette Hanna, Mishita Goel, Sara Bedrose, Dingfeng Li, Sanford Baim
Summary: This study aimed to investigate physicians' preferences and sequential treatment patterns of osteoporosis therapy. The study found that alendronate was the most common initial treatment, and denosumab was the most common second course of treatment prescribed.
ENDOCRINE PRACTICE
(2022)
Article
Endocrinology & Metabolism
M. M. Delsmann, A. Strahl, M. Muhlenfeld, N. M. Jandl, F. T. Beil, C. Ries, T. Rolvien
Summary: The study found a high prevalence of low bone mineral density in elderly patients with end-stage osteoarthritis scheduled for total hip arthroplasty. Routine DXA measurements should be considered in these patients to prevent undiagnosed and untreated osteoporosis, which could impact the success of osseointegration and other clinical outcomes.
OSTEOPOROSIS INTERNATIONAL
(2021)
Article
Endocrinology & Metabolism
Namki Hong, Heajeong Park, Chang Oh Kim, Hyeon Chang Kim, Jin-Young Choi, Hwiyoung Kim, Yumie Rhee
Summary: Dual-energy X-ray absorptiometry (DXA)-based bone radiomics scores from hip images may improve hip fracture prediction in older women. The study showed that an increase in bone radiomics score was associated with an elevated risk of incident hip fracture.
JOURNAL OF BONE AND MINERAL RESEARCH
(2021)
Article
Endocrinology & Metabolism
Nicholas C. Harvey, John A. Kanis, Enwu Liu, Cyrus Cooper, Mattias Lorentzon, Jennifer W. Bea, Laura Carbone, Elizabeth M. Cespedes Feliciano, Deepika R. Laddu, Peter F. Schnatz, Aladdin H. Shadyab, Marcia L. Stefanick, Jean Wactawski-Wende, Carolyn J. Crandall, Helena Johansson, Eugene McCloskey
Summary: In the WHI study, associations between baseline appendicular lean mass (ALM) and incident fractures, falls, and mortality in older postmenopausal women were investigated. Higher ALM/height(2) was associated with lower risk of MOF but higher risk of death. These associations were independent of prior falls but attenuated by other factors such as FRAX probability and FN BMD T-score.
JOURNAL OF BONE AND MINERAL RESEARCH
(2021)
Article
Endocrinology & Metabolism
Carrie Ye, Suzanne N. Morin, Lisa M. Lix, Eugene V. McCloskey, Helena Johansson, Nicholas C. Harvey, John A. Kanis, William D. Leslie
Summary: The study assessed the performance of the Fracture Risk Assessment Tool (FRAX) in predicting incident fractures in men with prostate cancer. The results showed that FRAX reliably predicts fractures in this population.
JOURNAL OF BONE AND MINERAL RESEARCH
(2023)
Article
Medicine, General & Internal
Se-Won Lee, Younghyun Yoon, Junhyuk Kwon, Jun-Young Heu, Jihyo Hwang
Summary: The clinical significance of BMD discordance between the hip and spine for hip fractures was evaluated in this study. The results showed that the rates of BMD discordance and low hip discordance were significantly higher in the hip fracture group than in the non-fracture group, indicating a higher risk of hip fractures.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Endocrinology & Metabolism
Lorenzo Grassi, Sami P. P. Vaananen, Lars Jehpsson, Osten Ljunggren, Bjorn E. Rosengren, Magnus K. K. Karlsson, Hanna Isaksson
Summary: This study evaluated the ability of a method to predict incident hip fractures based on the reconstruction of 3D hip anatomy from a 2D DXA image and subject-specific FE-based prediction of proximal femoral strength. The results showed that FE-predicted proximal femoral strength was a better predictor of hip fractures than aBMD, suggesting potential for improving fracture risk predictions in a clinically feasible manner.
JOURNAL OF BONE AND MINERAL RESEARCH
(2023)
Article
Biochemistry & Molecular Biology
Nerea Ugartondo, Nuria Martinez-Gil, Monica Esteve, Natalia Garcia-Giralt, Neus Roca-Ayats, Diana Ovejero, Xavier Nogues, Adolfo Diez-Perez, Raquel Rabionet, Daniel Grinberg, Susanna Balcells
Summary: Osteoporosis, a common metabolic bone disorder, is often treated with nitrogen-containing bisphosphonates. Prolonged use of bisphosphonates may lead to rare atypical femoral fractures, possibly due to rare mutations in the CYP1A1 gene.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Medicine, General & Internal
Kaleen N. Hayes, Elizabeth M. Winter, Suzanne M. Cadarette, Andrea M. Burden
Summary: Bisphosphonates are the primary treatment for osteoporosis, and a drug holiday of two to three years is recommended for most patients after long-term use to reduce the risk of adverse events. Duration of bisphosphonate effects during the drug holiday and individual patient factors should be considered when determining the appropriate time to stop therapy.
JOURNAL OF CLINICAL MEDICINE
(2021)
Review
Medicine, General & Internal
SeokJoon Hwang, Minsu Seo, Dongin Lim, Min Suk Choi, Jin-Woo Park, Kiyeun Nam
Summary: This literature review investigated the characteristics and management of bisphosphonate-associated bilateral atypical femoral fractures (AFFs). A comprehensive analysis of 43 patients with bilateral AFFs revealed that 67% had prodromal symptoms, 49% occurred simultaneously, and 51% occurred sequentially. X-ray was used for initial diagnosis, with 53% having complete fractures. Surgical treatment was performed for all patients, except for those with incomplete fractures who received either surgical or medical treatments. Teriparatide was the most commonly used medication after bisphosphonate discontinuation.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Environmental Sciences
Bastien Bourrion, Cecile Souty, Lucie Fournier, Ana-Maria Vilcu, Thierry Blanchon, Pierre-Yves Boelle, Thomas Hanslik, Mathilde Francois
Summary: The study found that in real life, the use of bisphosphonates does not appear to reduce hospitalization rates for hip fractures, possibly due to it being prescribed for primary prevention and for a duration too short to be effective.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
(2021)
Article
Endocrinology & Metabolism
Sebastian Strom Ronnquist, Bjarke Viberg, Morten Tange Kristensen, Henrik Palm, Jens-Erik Beck Jensen, Carsten Fladmose Madsen, Kristina E. Akesson, Soren Overgaard, Cecilia Rogmark
Summary: Research on younger patients with hip fractures is limited. This study provides valuable knowledge about patient and injury characteristics, and explores the role of DXA in assessing bone mineral density at the time of fracture. Risk factors for osteoporosis and fractures were found to be abundant among young patients, with a much higher prevalence of osteoporosis compared to the general population.
OSTEOPOROSIS INTERNATIONAL
(2022)
Article
Critical Care Medicine
Seung-Ju Kim, Yun Jae Cho, Dong-Woo Lee
Summary: This study found low adherence to osteoporosis treatments in elderly patients following hip fracture, with 6-month subcutaneous denosumab injection being the preferred choice and exhibiting significantly lower discontinuation rates.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
(2021)
Review
Critical Care Medicine
Annalisa De Cicco, Giuseppe Toro, Francesco Oliva, Umberto Tarantino, Alfredo Schiavone Panni, Nicola Maffulli
Summary: The study analyzed 17 patients with APFF, finding that all cases occurred in females with an average age of 75.9 years. Conservative management was effective for incomplete fractures, while complete fractures required open reduction and internal fixation. The study suggests that APFF shares many clinical and imaging characteristics with AFF.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
(2021)
Article
Rheumatology
S. Louis Bridges, Steffen Gay
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Joshua F. Baker, Daniel G. Baker
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
William Neal Roberts Jr, Edward R. Lew, Matthew H. Liang
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Daniel A. Albert
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Virginia D. Steen, Thomas A. Medsger
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Patricia Woo, Ross E. Petty
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
H. James Williams, Grant W. Cannon, Daniel O. Clegg
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Biographical-Item
Rheumatology
Daniel J. Wallace
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Ann K. Rosenthal, Mary E. Csuka, Paul Halverson
Summary: Dr. McCarty is a giant in the field of rheumatology. His clinical and scientific discoveries have had a major impact and benefited many patients. He has been an exceptional mentor and role model, influencing our clinical practice styles, the importance we place on clinical observation, and our approach to scientific questions.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Arthur Weinstein
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Marc C. Hochberg
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Richard M. Silver
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Anthony M. Reginato, Michelle A. Petri, Jonathan Kay
Summary: Bauer and Ropes were influential figures in the field of rheumatology, making significant contributions through clinical observation and laboratory research. They were also exceptional mentors and leaders in the field.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
Mary K. Crow, Josef S. Smolen
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)
Article
Rheumatology
James S. Louie
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
(2024)